De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival

M. Mittelbronn^*, D. Capper, B. Bunz, K. Dietz, B. Goeppert, R. Ajaaj, G. Tabatabai, F. Stubenvoll, H. Schlaszus, A. S. Merseburger, R. Becker, D. Freudenstein, W. Wick, M. Weller, R. Meyermann, P. Simon

^*Corresponding author for this work